These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34313238)

  • 41. Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience.
    Wah TM; Lenton J; Smith J; Bassett P; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Kimuli M; Cartledge J
    Eur Radiol; 2021 Oct; 31(10):7491-7499. PubMed ID: 33825033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety.
    Guo J; Arellano RS
    J Endourol; 2020 Oct; 34(10):1021-1027. PubMed ID: 32498630
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of Contrast-Enhanced Ultrasound Scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases.
    Zeccolini G; Del Biondo D; Cicero C; Casarin A; Guarise A; Celia A
    Urologia; 2014; 81 Suppl 23():S1-8. PubMed ID: 24665032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Long-term follow-up of renal cell carcinomas T1a treated by percutaneous radiofrequency].
    Amadane N; André M; Daniel L; Coulange C; Baboudjian M; Michel F; Gondran-Tellier B; Vanacore D; Lechevallier E; Boissier R
    Prog Urol; 2021 Sep; 31(10):576-583. PubMed ID: 33593696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility of Computed Tomography-guided Percutaneous Renal Cryoablation Under Local Anesthesia: A Single Center Experience in Taiwan.
    Lin YT; Hung SW; Liu MC; Chiu KY; Chai JW; Lin JC
    Anticancer Res; 2023 Apr; 43(4):1699-1708. PubMed ID: 36974775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
    Kim HJ; Park BK; Park JJ; Kim CK
    Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
    Schmit GD; Atwell TD; Leibovich BC; Callstrom MR; Kurup AN; Woodrum DA; Charboneau JW
    AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous microwave ablation of renal masses in a UK cohort.
    John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N
    BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
    Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
    Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.
    Beksac AT; Rivera-Sanfeliz G; Dufour CA; Nseyo U; Hamilton Z; Berquist SW; Hassan AE; Raheem OA; Wang S; Wake RW; Gold RE; Derweesh IH
    World J Urol; 2017 Apr; 35(4):633-640. PubMed ID: 27484204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores.
    Efthymiou E; Velonakis G; Charalampopoulos G; Mazioti A; Brountzos E; Kelekis N; Filippiadis D
    Eur Radiol; 2023 Nov; 33(11):7388-7397. PubMed ID: 37318604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity.
    Miller AJ; Kurup AN; Schmit GD; Weisbrod AJ; Boorjian SA; Thompson RH; Lohse CM; Kor DJ; Callstrom MR; Atwell TD
    J Endourol; 2015 Jun; 29(6):671-6. PubMed ID: 25386995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety Considerations and Local Tumor Control Following Percutaneous Image-Guided Cryoablation of T1b Renal Tumors.
    Hebbadj S; Cazzato RL; Garnon J; Shaygi B; Buy X; Tsoumakidou G; Lang H; Gangi A
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):449-458. PubMed ID: 29075877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience.
    Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Patterson DE; Chow GK; Blute ML
    Radiology; 2007 Apr; 243(1):276-83. PubMed ID: 17329689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney.
    Meng H; Yang H; Jia H; Pan F; Dong X; Liu B; Li C
    Int J Hyperthermia; 2021; 38(1):691-695. PubMed ID: 33899668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors.
    Hao G; Hao Y; Cheng Z; Zhang X; Cao F; Yu X; Han Z; Liu F; Mu M; Dou J; Li X; Dupuy DE; Yu J; Liang P
    Int J Hyperthermia; 2018; 35(1):62-70. PubMed ID: 29807450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CT-Guided Percutaneous Cryoablation in Renal Cell Carcinoma: Factors Affecting Local Tumor Control.
    Yamanaka T; Yamakado K; Yamada T; Fujimori M; Takaki H; Nakatsuka A; Sakuma H; Sugimura Y
    J Vasc Interv Radiol; 2015 Aug; 26(8):1147-53. PubMed ID: 26123809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.